The emergence of drug resistance combined with limited success in the discovery of newer and effective antimicrobial chemotherapeutics poses a significant challenge to human and animal health. Nanoparticles may be an approach for effective drug development and delivery against infections caused by multi-drug resistant bacteria. Here we discuss nanoparticles therapeutics and nano-drug delivery against bacterial infections. The therapeutic efficacy of numerous kinds of nanoparticles including nanoantibiotics conjugates, small molecules capped nanoparticles, polymers stabilized nanoparticles, and biomolecules functionalized nanoparticles has been discussed. Moreover, nanoparticles-based drug delivery systems against bacterial infections have been described. Furthermore, the fundamental limitation of biocompatibility and biosafety of nanoparticles is also conferred. Finally, we propose potential future strategies of nanomaterials as antibacterials.physical strength, electrical conductance, chemical reactivity and optical effects [11]. These criteria help in increasing the surface area, enhancing release of drug, reducing the dose required, and improving solubility and bioavailability of the compounds [12]. Moreover, these properties are also important for the diagnosis of microbial diseases with high sensitivity and selectivity and those with fluorescent properties or labeled with fluorescent dyes have also been employed for bacterial detection and susceptibility. In addition, inorganic nanoparticle-based diagnostic approaches depend upon the identification of known bacterial genome sequences by directing probes, and thus may not recognize altered and/or novel bacterial strains [13]. Furthermore, nanoparticles based specific drug targeting improve the therapeutic index, increase stability of drug, and decrease drug resistance. For example, silver nanoparticles affect Escherichia coli by forming complex with electron donor groups on amino acids and nucleic acids [12]. At present, liposomal drugs and polymer-drug conjugates have been approved for infectious diseases treatment, and many other antimicrobial nanoparticle formulations are under preclinical test [14].Gold nanoparticles have gained significant attention recently due to their tunable antimicrobial applications. Gold has been the subject of interest against bacterial infections for its biocompatibility and ease in conjugation with drugs and biomolecules. Gold conjugated with various drugs have shown to enhance their efficacy against bacteria. Gold nanoparticles coated with aminoglycosides have been found to be efficient antibacterial agents against various bacteria such as Staphylococcus aureus, Micrococcus luteus, E. coli and Pseudomonas aeruginosa [15]. In another study, after assessment of the surface chemistry of nanoparticles, the synergistic mechanism showed that hydrophobic cationic conjugated gold nanoparticles reduced the minimum inhibitory concentration (MIC) of fluoroquinolone against multidrug resistant by 8-16 times [16]. More recently, formulatio...